Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.
Since Nov 18, 2025
Transactions
5
Purchases
0
Sales
5
Purchase value
$0.00
Sale value
$7.67M
Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.
John KielyDirector
4
Filed Aug 14, 2026Period of report Aug 13, 20260001628280-26-057147
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleAug 13, 2026
Class A Common StockF1
50,000
$17.64
$882.00K
210,252
Direct
Filing footnotes · 2
F1The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.26 to $17.88 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote.
F2Represents a charitable donation of common stock to a donor advised fund.
Filed Aug 13, 2026Period of report Aug 12, 20260001628280-26-056757
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleAug 12, 2026
Class A Common StockF1
146,403
$17.51
$2.56M
253,390
Direct
Filing footnotes · 1
F1The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.40 to $17.67 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote.
Filed Aug 13, 2026Period of report Aug 11, 20260001628280-26-056754
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleAug 12, 2026
Class A Common StockF2
210,000
$17.40
$3.65M
35,171
Direct
SaleAug 11, 2026
Class A Common StockF1
6,613
$17.70
$117.05K
245,171
Direct
Filing footnotes · 2
F1The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.65 to $17.73 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote.
F2The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.25 to $17.67 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote.
Filed May 12, 2026Period of report May 11, 20260001628280-26-034106
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMay 11, 2026
Class A Common StockF1
34,819
$12.94
$450.56K
93,660
Direct
Filing footnotes · 1
F1The price included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.75 to $13.27 per share, inclusive. The Reporting Person undertakes to provide Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.